18 Jun Prodesse releases virus detection assay in Europe
Milwaukee, Wis. – Prodesse, Inc., a Milwaukee-based biotechnology company, has announced the European and international release of its assay used for detection of the human metapneumovirus.
Known as Pro hMPV, it is designed to more rapidly detect human metapneumovirus (hMPV), a respiratory virus.
The assay, now available in the United States as a research-only product for non-clinical use, is the second incarnation of Prodesse’s hMPV product. The product is undergoing clinical trials, and Prodesse anticipates submission for Food and Drug Administration 510(k) clearance this summer.
• FDA clears Prodesse respiratory virus test
• Prodesse’s flu test receives FDA clearance
• Prodesse begins clinical trials for flu virus detection